Study to Assess the Effect of Ofatumumab in Treatment Naïve, Very Early RRMS Patients Benchmarked Against Healthy Controls.

PHASE4Active, not recruitingINTERVENTIONAL
Enrollment

180

Participants

Timeline

Start Date

January 25, 2022

Primary Completion Date

February 4, 2025

Study Completion Date

February 16, 2026

Conditions
Relapse Remitting Multiple Sclerosis
Interventions
DRUG

Ofatumumab

20mg subcutaneous injection

Trial Locations (36)

20007

MedStar Health, Washington D.C.

26506

West Virginia University Hospital, Morgantown

27607

Velocity Clinical Research, Raleigh

30309

Shepherd Center, Atlanta

32308

Tallahassee Neurological Clinic, Tallahassee

32514

Emerald Coast Neurology, Pensacola

32610

Univ of Florida College of Medicine, Gainesville

32714

Neurology of Central FL Res Ctr, Altamonte Springs

32751

Neurology Associates PA, Maitland

32806

Orlando Health Clinical Trials, Orlando

33486

First Choice Neurology, Boca Raton

33612

University Of South Florida, Tampa

37922

Sibyl Wray MD Neurology PC, Knoxville

45408

Neurology Diagnostics Inc, Dayton

53226

Medical College of Wisconsin, Milwaukee

70121

Ochsner Cancer Institute, New Orleans

73104

Multiple Sclerosis Center of Excellence of OMRF, Oklahoma City

77030

UT Health Science Center, Houston

78258

Lonestar Neurology of San Antonio, San Antonio

80045

UC Health Neuroscience Ctr, Aurora

85013

Barrow Neurological Clinics at St Josephs Hospital and MC, Phoenix

85032

Arizona Neuroscience Research LLC, Phoenix

85226

MD First Research, Chandler

89521

Renown Institute for Neurosciences, Reno

90033

Keck School of Medicine, Los Angeles

90048

Regina Berkovich MD PhD Inc, West Hollywood

98034

Evergreen Health Multiple Sclerosis Center, Kirkland

98405

MultiCare Neuroscience Center of Washington, Tacoma

90509-2910

Lundquist Inst BioMed at Harbor, Torrance

01655

University of Massachusetts Medical School, Worcester

48202 2689

Henry Ford Hospital, Detroit

07601

Neuroscience Institute at Hackensack, Hackensack

87131-0001

University of New Mexico, Albuquerque

19107-5098

Thomas Jefferson University Hospital, Philadelphia

75390-9034

Univ of Texas Southwest Med Center, Dallas

00968

Caribbean Center for Clinical Research, Inc, Guaynabo

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY